Carbon Dioxide
Approved medicineAlso known as CO2 - Carbon dioxide, Carbonic anhydride.
Recent clinical, regulatory, research and industry developments relating to this drug.
Spatial pattern and structural transformation of industrial carbon dioxide emissions in China
Persistent silicate weathering and carbon dioxide uptake in eolian drylands since the late Pliocene
Applied Physiology of Oxygen Toxicity: Mechanisms in Humans
Interaction of water and supercritical carbon dioxide (ScCO2) with rock and joints
Rising carbon dioxide is supercharging grass growth in African savannas, study finds
Cities need robust carbon dioxide removal strategies to meet net-zero targets
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion
The underpinnings of the BOLD functional magnetic resonance imaging signal.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes7
Journals, researchers & institutions
- Plant, cell & environment1
- Resuscitation1
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Andersen GØ1
- Bellomo R1
- Buti S1
- de Boer HJ1
- Eastwood G1
- Flaa A1
- Huber M1
- Kahlon PS1
- Austin Hospital1
- Copernicus Institute of Sustainable Development1
- Groningen Institute for Evolutionary Life Sciences1
- Laboratory of Molecular Biology1
- Laboratory of Plant Physiology1
- Max Planck Institute for Biological Cybernetics1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials